Clinical Trial Update: Study to Evaluate the Safety, Tolerability, and Immunogenicity of Hantaan and Puumala Virus DNA Vaccines [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the safety, tolerability, and immunogenicity of Hantaan and Puumala virus DNA vaccines for hemorrhagic fever with renal syndrome. The s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemorrhagic Fever with Renal Syndrome

Drugs mentioned

• Hantaan virus DNA vaccine
• Puumala virus DNA vaccine

Snippet

Sponsor: U.S. Army Medical Research and Development Command | Conditions: Hemorrhagic Fever With Renal Syndrome | Phase 1 | Status: COMPLETED